JPIAMR took part in the 2nd Annual Plenary Assembly of the AMR Multi-Stakeholder Partnership Platform (MSPP) that was held on 16 November in Jeddah, Saudi Arabia. The MSPP was established and facilitated by the Quadripartite organizations (FAO, UNEP, WHO and WOAH) in 2023 with the aim to catalyse a global movement for action against antimicrobial resistance (AMR) by fostering cooperation between a diverse range of stakeholders at all levels across the One Health spectrum.
The platform’s members shared progress and experiences since its inception and worked together on formulating concrete steps for implementation of the UNGA political declaration on AMR from September this year.
The annual assembly was held in conjunction with the Fourth High-level Ministerial Conference on AMR, which highlighted efforts and ambitions in infection prevention, diagnostics, and research and innovation. The importance of inclusivity of voices and perspectives and of securing sustainable financial resources to support all aspects of AMR mitigation was highlighted by panelists and speakers.
A few key points from JPIAMR’s perspective:
- Basic research and innovation, and good scientists, are needed for sustainable access to antibiotics.
- Repeated calls for comprehensive funding for research and innovation with a One Health perspective, from public and private sector representatives.
- Research and knowledge valorisation in infection prevention, diagnostics, and optimal use of existing antibiotics are accessible solutions for immediate action.
- To tackle AMR, we need to also recognize how it is situated in a system of poor basic health care, lack of clean water and sanitation, impact from conflicts and climate change, and the vulnerable balance between access to/excess of medications.
